Pharmacokinetic of Posaconazole in Critically Ill Patients

Pharmacokinetic of Intravenous Posaconazole in Critically Ill Patients

The posaconazole pharmacokinetic in critically ill patients will be studied in a prospective, non-interventional, monocentric observational trial.

The posaconazole pharmacokinetic in critically ill patients will be studied in a prospective, non-interventional, monocentric observational trial. Plasma specimens will be retrieved on consecutive days (max. 7 days) in order to measure posaconazole levels during the treatment episode.

Inclusion Criteria:

• treatment with intravenous posaconazole
• critically ill patient
• written declaration of consent

Exclusion Criteria:

- no declaration of consent